SL
EW icon

Salomon & Ludwin’s Edwards Lifesciences EW Stock Holding History

Salomon & Ludwin’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13K Sell
141
-1
-0.7% -$84 ﹤0.01% 1464
2026
Q1 		$11.5K Hold
142
– – ﹤0.01% 1454
2025
Q4 		$12K Sell
142
-42
-23% -$3.45K ﹤0.01% 1327
2025
Q3 		$14.2K Buy
+184
New +$14.4K ﹤0.01% 1046

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Salomon & Ludwin's EW Position: Q2 2026 in Review

Salomon & Ludwin reduced its Edwards Lifesciences (EW) stake by 0.7% in Q2 2026, selling an estimated $84 and leaving 141 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #1464.

Salomon & Ludwin first reported a position in EW in Q3 2025 and has held it in 4 quarters since. The position peaked at $14.2K in Q3 2025. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Salomon & Ludwin held 141 shares of Edwards Lifesciences worth $13K as of Q2 2026.
  • Salomon & Ludwin sold 1 Edwards Lifesciences share in Q2 2026, an estimated $84.
  • Edwards Lifesciences made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1464 holding.
  • Salomon & Ludwin first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 4 quarters since.
  • Salomon & Ludwin's Edwards Lifesciences position peaked at $14.2K in Q3 2025.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.